Genfit S A Revenue per Employee (GNFT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Genfit S a   (NASDAQ: GNFT)
 

Genfit S A 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 85.82% in the fourth quarter 2024, year on year to cumulative value of $79 million, Genfit S A 's revenue per employee grew on a trailing twelve months basis to $ 571,595. The productivity of Genfit S A 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 164 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 1591, from total ranking in previous quarter at 1843. Genfit S A has 139 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GNFT Revenue per Employee (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Revenue Change 85.82 % - - - 43.7 %
Sales per Employee (TTM) $ 571,595 307,605 307,605 307,605 307,605
GNFT's Total Ranking # 1591 # 1843 # # #
Seq. Revenue Change - - - - -

GNFT Company Profile >> Back to GNFT Efficiency Comparisons >> Compare GNFT Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 26
Healthcare Sector # 165
Overall Market # 1591

Revenue per Employee Statistics
High Average Low
$ 689,557 $ 362,562 $ 62,511
(Dec 31 2021)   (Dec 31 2020)



Financial Statements
Genfit S A 's Revenue MRQ $ 79 Millions Visit GNFT's Income Statement
Genfit S A 's Revenues TTM $ 79 Millions Visit GNFT's aggregate revenue growth
What are GNFT's Sales? Visit GNFT's Sales by Segment




Other Ratios
Genfit S A 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
GNFT's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for GNFT's Competitors
Revenue per Employee for GNFT's Suppliers
Revenue per Employee for GNFT's Customers

You may also want to know
GNFT's Sales Growth Rates GNFT's Pe Price to earnings ratio GNFT's Receivables Turnover Ratio GNFT's Stock Quote
GNFT's Net Income Growth Rates GNFT's Ps Price to Sales ratio GNFT's Sales per Employee GNFT's Asset Turnover Ratio
GNFT's Net Margin GNFT's Pb Price to Book ratio GNFT's Financial Strength Ratios GNFT's Dividend Payout Ratio
Date modified: 2026-06-22T16:58:57+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2024Number of Employees Dec 31 2024
Abbvie Inc   988,315.79 $ 56,334.000  Million 57,000 
Krystal Biotech Inc   984,796.61 $ 290.515  Million 295 
Alector Inc   976,291.26 $ 100.558  Million 103 
Theratechnologies Inc   975,750.00 $ 85.866  Million 88 
Journey Medical Corp  967,827.59 $ 56.134  Million 58 
Masimo Corp  952,000.00 $ 2,094.400  Million 2,200 
Lifevantage Corp  947,408.07 $ 211.272  Million 223 
Corcept Therapeutics Inc  924,712.33 $ 675.040  Million 730 
Regeneron Pharmaceuticals Inc   921,609.34 $ 14,202.000  Million 15,410 
Elutia Inc   911,807.69 $ 23.707  Million 26 
Novavax inc   910,763.68 $ 682.162  Million 749 
Mirum Pharmaceuticals Inc   905,612.90 $ 336.888  Million 372 
Eli Lilly And Company  900,854.00 $ 45,042.700  Million 50,000 
Alnylam Pharmaceuticals Inc   899,297.20 $ 2,248.243  Million 2,500 
Biomarin Pharmaceutical Inc  886,033.84 $ 2,853.915  Million 3,221 
Proqr Therapeutics N v   882,233.33 $ 21.174  Million 24 
Anaptysbio Inc   877,692.31 $ 91.280  Million 104 
Y mabs Therapeutics inc   876,840.00 $ 87.684  Million 100 
Blueprint Medicines Corporation  874,268.04 $ 508.824  Million 582 
Eton Pharmaceuticals Inc   872,977.27 $ 38.411  Million 44 
Patterson Companies Inc   856,800.00 $ 6,511.680  Million 7,600 
Merck and Co Inc   855,573.33 $ 64,168.000  Million 75,000 
Pfizer Inc  848,360.00 $ 63,627.000  Million 75,000 
Carlisle Companies Incorporated  848,067.80 $ 5,003.600  Million 5,900 
Galapagos Nv  845,827.07 $ 308.727  Million 365 
Pacira Biosciences inc   845,556.09 $ 700.966  Million 829 
Akebia Therapeutics Inc   825,670.10 $ 160.180  Million 194 
Tg Therapeutics Inc   824,571.43 $ 329.004  Million 399 
Ptc Therapeutics inc   814,106.96 $ 806.780  Million 991 
Lipocine Inc   809,732.29 $ 11.336  Million 14 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.